DNMT3A mutations are the most frequently observed genetic abnormalities in AML, predominantly in older patients, occurring in approximately 20–30% of adult AML cases and over 30% of AML with a normal karyotype. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.